| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2775469 | Experimental and Molecular Pathology | 2011 | 7 Pages |
To investigate the potential transcriptional regulation and signal pathway of a single microRNA in ischemia-induced retinal neovascularization (NV), we used oxygen-induced retinopathy (OIR) in establishing retinal NV model, and quantitative real-time reverse transcriptase PCR analyzing a microRNA (miR-126) alteration. The mice were treated with plasmid pCMV-MIR-126/liposome mixture intravitreal injection, using pCMV-MIR/liposome mixture as control. The expression levels of VEGF, IGF-2 and HIF-1α, and the level changes of total and phosphorylated p38, ERK in retina from OIR mice were determined by western blot analysis. The effects of miR-126 on retinal NV in OIR mice were identified with fluoresecin angiography and H & E staining. No effect of miR-126 intravitreal injection on retinal vessels was performed with CD31 stained retinal sections. Our results showed that miR-126 was significantly decreased in retina from OIR mice. We confirmed that restoration of miR-126 in retina overcame the high levels of VEGF, IGF-2 and HIF-1α through downregulating p38 and ERK signaling molecules in OIR model, and that miR-126 intravitreal injection reduced retinal NV in OIR model. These results suggest that miR-126 might play a potential transcriptional role in the pathogenesis in diabetic retinopathy.
Research highlights► The molecular mechanism of the pathogenesis of ischemia-induced retinal neovascularization (NV) is not completely clear. ► MicroRNAs (miRNA) might play an important role in transcriptional regulation of above growth factors in retina. >microRNA-126 level was significantly decreased in retina from oxygen-induced retinopathy (OIR) mice. ► Restoration of miR-126 level in retina decreased the levels of angiogenic growth factors and disrupted the retinal NV in OIR mice. ► Deep signaling mechanism related to p38 and ERK MAPK pathway was involved in the regulation of above angiogenic growth factors by miR-126.
